Skip to main content

NIH awards $25 million to UNC’s Global HIV Clinical Trials Unit

November 30, 2020

  The National Institutes of Health has awarded University of North Carolina’s Institute for Global Health & Infectious Diseases nearly $25 million over seven years to continue operating its Global HIV Clinical Trials Unit, or CTU. The new funding will support HIV treatment and prevention in adults, children and pregnant women at four research sites … Continued

ACTG honors David Wohl, MD, with first Charles van der Horst Humanitarian Award

November 24, 2020

ACTG names second new award for former UNC neurology professor, Kevin Robertson The national AIDS Clinical Trials Group expanded its annual recognition program in 2020 with two new awards named for University of North Carolina faculty members who died in 2019: Charles van der Horst, MD, an infectious diseases physician and researcher, and Kevin Robertson, … Continued

Congolese physician wins Rotary fellowship to study public health

November 19, 2020

The year was 1993. Alexis Mwanza, then 17, found himself huddled on top of a train, fleeing violence in his home town in the Democratic Republic of Congo by leading nine of his family members 500 miles away to Mbuji Mayi. As a displaced refugee in that city, Mwanza watched Red Cross workers and other … Continued

Ciccone wins clinical research award from ASTMH

November 19, 2020

Research looks at leveraging diagnostic technology to improve management of pediatric infections in low-resource settings Emily Ciccone, MD, MHS, a UNC clinical instructor and infectious diseases fellow, recently won first prize in the clinical research award session of the 2020 annual meeting of the American Society of Tropical Medicine and Hygiene. The award recognizes excellence … Continued

Promising COVID-19 drug is part of global study being led by UNC researchers

November 16, 2020

  Last week’s authorization by the U.S. Food and Drug Administration for emergency use of bamlanivimab feels like a shot in the arm, so to speak, for David Wohl, MD, a UNC infectious diseases physician and researcher. A monoclonal antibody developed by Eli Lilly to treat mild to moderate COVID-19, bamlanivimab is one of the … Continued

Meet the 2020 inaugural Charlie Scholars

October 29, 2020

Six students from Dzama, Malawi — three girls and three boys — have received scholarships to attend private school and receive individual tutoring as the inaugural class of “Charlie Scholars.” The Charlie van der Horst Malawi Scholars Program, administered by UNC Project-Malawi and the UNC Medical Foundation, honors the late UNC infectious diseases physician who … Continued

HIVMA names Adimora 2020 clinical educator of the year

October 29, 2020

The HIV Medicine Association, or HIVMA, has honored UNC infectious diseases professor Ada Adimora, MD, MPH, with its 2020 Clinical Educator Award. The award, presented during the annual IDWeek conference, recognizes Adimora’s “extraordinary contributions to advancing clinical education, with a focus on disseminating her research on the drivers of HIV-related racial disparities.” Adimora is the … Continued

Taking the long view: Cohen delivers Richardson Lecture

October 13, 2020

Human beings will continue to suffer from infectious diseases, some of them contagious. To fight a new disease, infectious disease physicians first work to determine the rules that govern the disease, its spread, and the gravity of the infection. Those rules then determine our prevention and treatment strategies, Institute Director Myron Cohen, MD, told his … Continued

HIV Cure Center, Cell Microsystems to further develop single-cell diagnostic assay

October 12, 2020

Cell Microsystems and UNC’s HIV Cure Center will continue their work on developing an automated assay that can measure single cells for latent HIV, thanks to a two-year, $1.65 million contract from the National Institutes of Health. The new contract, a highly competitive phase II Small Business Innovation Research award, affirms the partners’ success resulting … Continued

‘Someone who looks like you’

October 7, 2020

Ernest Grant, RN, PhD, FAAN, president of American Nurses Association and an African American, shares why he is participating in COVID-19 vaccine trial   Spending a few hours at a University of North Carolina Health clinic, giving his health history and receiving an injection, might not be Ernest Grant’s favorite way to spend a Monday … Continued

Global survey aims to measure pandemic’s effects on sexual and reproductive health

October 6, 2020

  The expanding COVID-19 pandemic has transformed the social lives of people across the world. A collaboration between researchers at the UNC Institute for Global Health & Infectious Disease, the London School of Hygiene and Tropical Medicine, and the Academic Network for Sexual and Reproductive Health and Rights Policy is seeking to discover the effects … Continued

African American women perceive systemic barriers to accessing HIV prevention care

September 20, 2020

Black women in the southern United States are less likely to seek HIV prevention and treatment services because they don’t trust the health care system, according to a study in the September/October issue of The Journal of the Association of Nurses in AIDS Care (JANAC) by Schenita Randolph, PhD, MPH, at Duke University School of Nursing. … Continued

Convalescent plasma clinical trial ramps up

September 7, 2020

On the heels of FDA authorization of convalescent plasma as a treatment for COVID-19, UNC researchers are conducting a clinical trial to determine the safety and efficacy of plasma that includes a higher amount of neutralizing antibodies against SARS-CoV-2. The new Coronavirus-inactivating Plasma (CoVIP) research clinical trial is designed to determine the safety and efficacy … Continued

Wohl launches clinical trial, one of 25 sites nationally testing COVID-19 treatments

September 1, 2020

  UNC Institute for Global Health and Infectious Diseases researchers have begun phase 2 and phase 3 evaluations of promising treatments for COVID-19. The UNC School of Medicine joins more than 25 initial sites participating in the clinical trials through ACTIV-2, a public-private partnership sponsored by the NIH’s National Institute of Allergy and Infectious Diseases … Continued

UNC-led consortium to study HIV-related cancers in sub-Saharan Africa

August 24, 2020

A team of UNC researchers are partnering with colleagues at four institutions in Africa to study HIV-associated malignancies. With a five-year, $6 million grant from the NIH’s National Cancer Institute, the research consortium will look at screening and diagnosing innovations for three cancers common to people with HIV: Kaposi sarcoma, cervical cancer and lymphoma. Leading … Continued

In memoriam: UNC Project-Malawi colleagues pay tribute to Dr. Peter Kazembe

August 20, 2020

Our dear friend, Dr. Peter Kazembe, a Malawian colleague, pediatrician and adjunct professor of medicine with the University of North Carolina’s Institute for Global Health and Infection Diseases, died on August 11, 2020 at the age of 65 while receiving treatment for cancer in South Africa. He is survived by his wife, Hilda, and three … Continued

Remembering Steve Meshnick: Colleague, mentor and friend

August 6, 2020

“There are few people like him,” as a long-term collaborator and friend said. “Steve was so humble and generous that I don’t think he really understood the impact he had on the people around him. He profoundly changed for the better the lives of so many people he worked with and trained, without ever asking … Continued